OncoSec Medical Inc ONCSQ
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.02 / $0.03
- Shares Outstanding
- 5.96M
- Market Cap
- $5.96
- Volume/Avg
- 100 / 718
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 41
- Website
- https://www.oncosec.com
Valuation
|
Metric
|
ONCSQ
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ONCSQ
|
|---|---|
Quick Ratio | 0.51 |
Current Ratio | 0.89 |
Interest Coverage | −626.66 |
Quick Ratio
ONCSQ
Profitability
|
Metric
|
ONCSQ
|
|---|---|
Return on Assets (Normalized) | −130.07% |
Return on Equity (Normalized) | −733.19% |
Return on Invested Capital (Normalized) | −234.34% |
Return on Assets
ONCSQ
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|c#NH>fp | LOCK|#CC%? | $139B | |||
| Moderna Inc
MRNA
| LOCK|v^ntM$& | LOCK|$>Q | $103B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|F$#<CK | LOCK|q?hL | $96B | |||
| argenx SE ADR
ARGX
| LOCK|x!K!#M | LOCK|jWJ | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|xqJ<jd | LOCK|^C | $45B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|$g<Bn@g | LOCK|BrnY | $30B | |||
| Incyte Corp
INCY
| LOCK|?#$qSk? | LOCK|Cp | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|SP%^>< | LOCK|#!@ | $22B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|!L#WfJ | LOCK|$vVD | $22B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|<HJVD#^ | LOCK|#k | $15B |
United States